This 129-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market.  Some instrumentation is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman Coulter, BD, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG Molecular, Qiagen, Roche, Siemens, Tecan and Thermo Fisher.

The report also presents strategic assessments of current and emerging suppliers of molecular diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 129 pages